This review summarizes the research progress of IL-36RN mutations in the context of the onset and treatment of PPP, which is of great significance for improving the understanding of the pathogenesis of this disease and its treatment strategies. The gene discussed is IL36RN; the disease is palmoplantar pustulosis.